News
Patients with CLL have significantly reduced response to COVID-19 vaccine
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.
News
Protective levels of vitamin D achievable in SCD with oral supplementation
Vitamin D3 prophylaxis is a safe practice in sickle cell disease, and it is important to start this prophylactic treatment when the child is an...
News
DLBCL patients at academic centers had significantly better survival
Researchers suggested that academic centers might provide increased access to clinical trials, improved physician expertise, improved treatment...
News
Interleukin-27 increased cytotoxic effects of bone marrow NK cells in CLL
Interleukin-27 was able to increase cytotoxic effects of bone marrow natural killer cells in chronic lymphocytic leukemia (CLL).
News
REACH2: Ruxolitinib outperformed control treatment for refractory acute GVHD
Ruxolitinib was significantly more effective against acute graft-versus-host disease but produced more thrombocytopenia than did control treatment...
News
CLAM trial regimen shown safe, effective for r/r AML
High response rates and effective bridge to transplant shown.